5 days ago
Nifty Near 23,800 as Pharma Weakens, FMCG Seeks Rebound
The Nifty stock-market index has stayed below 24,000, making traders more careful.
The 23,800 level is an important floor that traders are watching.
Foreign investors have mostly increased their bets against the index, but some have also added bets that it will rise.
The Pharma Index has weakened after falling below an important chart pattern.
It could decline toward 26,160 or 25,500 if support fails.
The FMCG Index is also weak, but it is close to support around 45,400.
Because the FMCG Index looks oversold, buyers might appear and create a temporary bounce.
However, both sectors still face risks if support levels break.
Nifty’s sustained trading below 24,000 has made traders more cautious, while 23,800 remains a key support level.
FIIs increased index-futures short positions 18.8% week-on-week, although their long positions also rose nearly 40%.
The Nifty Pharma Index broke below its rising-wedge support, with 26,160 and then 25,500 identified as downside levels.
The Nifty FMCG Index is nearing support at 45,400, while oversold readings may allow a technical rebound.
Hindustan Unilever, ITC, Varun Beverages and Britannia are near important support levels, but any recovery faces resistance.
- Who
- Traders, foreign institutional investors, and companies in the pharma and FMCG sectors are the main participants discussed.
- What
- The article assesses technical support, resistance, and potential direction for the Nifty, Pharma Index, and FMCG Index.
- Where
- The Indian stock market, including the Nifty and its Pharma and FMCG indexes.
- When
- The analysis is presented as a Monday watchlist and uses data from the week ending Friday.
- Why
- To identify key levels that could signal further declines, a relief rebound, or renewed selling.
Further Downside
Potential Technical Rebound
Nifty direction
Further Downside
Trading below 24,000 and increased FII index-futures shorts support a cautious or bearish interpretation, with 23,800 acting as the key floor.
Potential Technical Rebound
The increase in FII long positions suggests some investors are tactically positioned for an upswing in the coming week.
Pharma outlook
Further Downside
The Pharma Index broke below rising-wedge support, its momentum indicators favor bears, and failure at 26,160 could expose 25,500.
Potential Technical Rebound
A quick reclaim of the broken wedge support could limit the decline, although rebounds may meet resistance near 26,800–26,850.
FMCG outlook
Further Downside
The FMCG Index remains below key resistance, and a decisive break below 45,400 could prolong its corrective trend.
Potential Technical Rebound
Oversold RSI readings and tiring MACD momentum could attract bargain hunters and produce a relief bounce if 45,400 holds.
Key facts
- Nifty support
- 23,800 is identified as a key support level, while the index has traded below 24,000 for multiple days.
- VIX
- The VIX remained near 10% and declined 5.6% on Friday.
- FII short positions
- FII index-futures short positions reached 269,527 contracts, up 18.8% week-on-week.
- FII long positions
- FII longs rose nearly 40% week-on-week to 33,689 contracts, the highest since early July.
- Pharma support
- The Nifty Pharma Index is watching 26,160, with 25,500 as the next downside area if support fails.
- FMCG support
- The Nifty FMCG Index is approaching support around 45,400.
- FMCG resistance
- A recovery in the FMCG Index could face resistance between 45,800 and 47,680.
Sources
Related news
Monday Watchlist: Pharma Strength, Financials Face Key Technical Test
Indian Indices Hold Support as Bullish Outlook Remains Intact
Nifty Outlook: Key Support Holds as Consolidation Continues
Nifty Holds 24,000 as 23,950 Becomes Key Support
Nifty Breaks Trendline Support as Selling Pressure Intensifies
Nifty falls fourth straight session; 24,200-24,250 key support
PepsiCo Expands India Investment, Targeting Top 10 Global Markets
Axis Securities Names 15 Stocks With Up To 40% Upside
HNGIL Threatens Insolvency Action Against Debt-Laden Bira 91 Maker
Sugar Spike Threatens FMCG Margins Ahead of Festive Season
